Nomura Holdings’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Nomura Holdings’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,691	Closed	-$207K	–	2544
2021 Q4	$207K	Buy	+12,691	New	+$214K	﹤0.01%	1818
2021 Q1	–	Sell	-23,000	Closed	-$568K	–	2364
2020 Q4	$568K	Buy	23,000 +14,000	+156%	+$464K	﹤0.01%	1204
2020 Q3	$373K	Sell	9,000 -9,000	-50%	-$414K	﹤0.01%	1070
2020 Q2	$862K	Buy	+18,000	New	+$1.39M	﹤0.01%	746
2019 Q3	–	Sell	-16,500	Closed	-$1.11M	–	1448
2019 Q2	$1.3M	Buy	16,500 +13,700	+489%	+$1.23M	0.01%	769
2019 Q1	$312K	Buy	2,800 +2,784	+17,400%	+$304K	﹤0.01%	980
2018 Q4	$2K	Sell	16 -1,849	-99%	-$192K	﹤0.01%	1160
2018 Q3	$236K	Buy	+1,865	New	+$197K	﹤0.01%	1148
2017 Q3	–	Sell	-3,023	Closed	-$366K	–	1661
2017 Q2	$366K	Buy	+3,023	New	+$350K	﹤0.01%	1297
2016 Q3	–	Sell	-2,704	Closed	-$384K	–	1432
2016 Q2	$384K	Buy	+2,704	New	+$394K	﹤0.01%	909
2014 Q4	–	Sell	-50,216	Closed	-$12M	–	2813
2014 Q3	$12M	Buy	50,216 +8,477	+20%	+$2.16M	0.03%	381
2014 Q2	$10.1M	Buy	41,739 +40,785	+4,275%	+$10.7M	﹤0.01%	436
2014 Q1	$316K	Sell	954 -52,248	-98%	-$17.6M	﹤0.01%	2049
2013 Q4	$3.63M	Buy	+53,202	New	+$3.07M	0.02%	473
2013 Q3	–	Sell	-17,832	Closed	-$791K	–	2661
2013 Q2	$791K	Buy	+17,832	New	+$609K	0.01%	1079

Other funds holding ICPT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nomura Holdings's ICPT Position: Q1 2022 in Review

Nomura Holdings sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2022, closing a stake of 12,691 shares — an estimated $207K sold.

Nomura Holdings first reported a position in ICPT in Q2 2013 and held it in 15 quarters. The position peaked at $12M in Q3 2014. 148 funds tracked by Wall St. Rank hold ICPT as of Q1 2022.

Nomura Holdings reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
Nomura Holdings sold 12,691 Intercept Pharmaceuticals, Inc. shares in Q1 2022, an estimated $207K.
Nomura Holdings first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 15 quarters.
Nomura Holdings's Intercept Pharmaceuticals, Inc. position peaked at $12M in Q3 2014.
148 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2022.

Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.